BPC-157 Stable vs GHK-Cu
Overview
BPC-157 Stable is primarily a healing & recovery peptide, while GHK-Cu is used for pain management.
This page compares BPC-157 Stable and GHK-Cu across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| BPC-157 Stable | GHK-Cu | |
|---|---|---|
| Category | Healing & Recovery | Pain Management |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | Compounding (Rx) — Apr 2026 |
| Typical dosage | 250-500 mcg | 1-3 mg |
| Frequency | daily | daily |
| Reported benefits | Same as BPC-157 with enhanced stability | Pain reduction through healing, anti-inflammatory, tissue regeneration |
| Reported side effects | Minimal, same as regular BPC-157 | Minimal side effects |
Key differences
Primary use. BPC-157 Stable is categorised under Healing & Recovery, while GHK-Cu falls under Pain Management. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. BPC-157 Stable: not FDA-approved; compounding permitted with a prescription as of April 2026. GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. BPC-157 Stable is typically dosed at 250-500 mcg (daily). GHK-Cu is typically dosed at 1-3 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking BPC-157 Stable and GHK-Cu has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between BPC-157 Stable and GHK-Cu?
- BPC-157 Stable is primarily a healing & recovery peptide, while GHK-Cu is used for pain management. BPC-157 Stable is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is BPC-157 Stable used for?
- Stabilized BPC variant.
- What is GHK-Cu used for?
- Anti-inflammatory tissue repair.
- Can you take BPC-157 Stable and GHK-Cu together?
- Some users combine peptides within a single protocol, but stacking BPC-157 Stable and GHK-Cu has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is BPC-157 Stable or GHK-Cu FDA-approved?
- BPC-157 Stable is not FDA-approved; compounding permitted with a prescription (as of April 2026). GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- BPC-157 Stable — full monograph: mechanism, research, dosing & references
- GHK-Cu — full monograph: mechanism, research, dosing & references